Current stock page

Catalysts

MAZE Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

MAZEMaze Therapeutics, Inc.

Healthcare / Biotechnology

Low Priority

Above Peers

NeutralEdge 6/10
$34.33−$1.76 (−4.88%)

Latest quote

  • Momentum
    83
  • Value
    42
  • Quality
    50
  • Risk resilience
    47
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
—

No upcoming reporting date is available yet.

AIQ Catalyst
AIQ 59/100

Momentum 83/100 and sentiment — before the next covered event.

Recent coverage
0 articles

Updated — · Sentiment not scored

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 83/100AIQ Edge 6/10 Above Peers
Beat rate
38%
3 of 8 reported periods
Average surprise
-526.6%
Across covered historical reports
Latest result
-4.0%
Nov 9, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 9, 2026—-$0.76-$0.79-4.0%$333.33K—
Aug 12, 2026—-$0.72-$0.76-6.0%$2.86M—
May 12, 2026—-$0.43-$0.45-4.7%$10.63M$20M
Mar 25, 2026—-$0.73-$0.65+11.0%$375K—
Nov 6, 2025—-$0.74-$0.66+10.8%——
Aug 12, 2025—-$0.79-$0.77+2.5%$3.13M—
May 14, 2025—-$0.76-$1.15-51.3%——
Mar 31, 2025—$0.45-$18.32-4171.1%——

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
14
Buy
12-month analyst target
$75.00
+118.47% versus current price
Based on 14 analyst observations. Targets are estimates, not predictions.
Low target
$75.00
+118.47% vs latest price
Average target
$75.00
+118.47% vs latest price
High target
$75.00
+118.47% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event date—

Upcoming earnings date not available yet.

Sentiment score—

News pressure around the setup.

Momentum score83

Where event reaction would show up first.

AIQ score59/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
14
Average target
$75.00
Target upside
118.47%
Target range
$75.00 - $75.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

No recent articles have a scored sentiment label.
Positive
0
Neutral
0
Negative
0

No recent company-specific news is available.

Open full news and sentiment

MAZE Catalysts FAQ

What are the next catalysts for MAZE stock?

MAZE's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move MAZE stock?

Upcoming events that could move MAZE include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could MAZE's next earnings report affect the stock?

MAZE's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive MAZE stock higher?

MAZE could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt MAZE stock?

MAZE could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.